Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Agenus Inc

NASDAQ: AGEN · Life Sciences · 2 alerts · CIK 1098972

Share price
$6.29Close, Nov 16
Market cap
$285M
Shares outstanding
45.25MLatest SEC cover page
Sector
Life Sciences
Industry
Biological Products, (No Diagnostic Substances)SIC 2836

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Agenus Inc filings on SEC EDGAR ↗

4:35 PM ET 10-Q
Financial Results

Agenus Q3 2026 Results: Net Income $2.73M, Down 95.7% YoY

Agenus Inc. reported its financial results for the quarter ended September 30, 2026, highlighting continued investment in its clinical-stage immunotherapy pipeline and strategic collaborations. The filing reflects the company's focus on managing operational costs while advancing lead candidates toward key regulatory and clinical milestones.

Key figure
Net income $2.73M · -95.7% YoY
8:02 AM ET 8-K
Financial Results

Agenus Financial Results

Agenus reported third-quarter 2026 financial results, achieving its third consecutive quarter of positive operating income and ending the period with $86.9 million in cash. The company highlighted the first marketing authorizations for its BOT+BAL combination in Armenia and confirmed its Phase 3 ROBBIN study in MSS colon cancer is on track for first patient enrollment in Q1 2027.

“We have moved beyond planning ROBBIN to mobilizing investigators and activating sites around the world in preparation for patient enrollment. The strong investigator engagement in Madrid and São Paulo, together with the peer-reviewed NEST and UNICORN publications, strengthens our confidence in the potential of BOT+BAL to change outcomes for patients with MSS colon cancer. We have a clear registrational path and financing aligned with our milestones to support our operations through 2031.”

Garo H. Armen, Ph.D., Chairman and Chief Executive Officer of Agenus

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.